Dr. Jonathan Troy Grennan is a clinical assistant professor in the Department of Medicine at the University of British Columbia, and a physician lead in the HIV/STI Program at the British Columbia Centre for Disease Control.
Dr. Grennan completed his undergraduate studies at McGill University, earning a Bachelor of Science in psychology, and obtaining a Bachelor of Science in nursing at the University of Toronto before going on to earn a master’s degree in medicine at McMaster University. He was a CTN Postdoctoral Fellow from 2011 to 2013. He also has training in tropical and travel medicine, having completed the Gorgas course in tropical medicine, and holds certification from the American Society of Tropical Medicine and Hygiene.
HIV has long been an area of interest for Dr. Grennan, dating back to his undergraduate days when he completed a research study in West Africa. He has since completed both clinical and research work in Swaziland and South Africa.
He is a principal investigator for CTN 292A and CTN 292B: HPV-SAVE, which is looking at the efficacy, safety, and tolerability of ablative therapies for anal dysplasia in HIV-positive men who have sex with men. Dr. Grennan is the co-lead of the CTN’S Co-infections and Related Conditions Core along with Dr. Ann Burchell.
